Developed by ISAC's Immunisations & Vaccines Working Group

This course is designed to help early career healthcare professionals build their understanding of how vaccinations can help to prevent antimicrobial resistance in relation to respiratory tract infections, like pneumonia.

Course Aims
The SARS-CoV-2 pandemic has highlighted the severe health consequences associated with respiratory tract infection. Pneumonia continues to be a global problem which requires treatment with antimicrobials. However, inappropriate prescribing of antimicrobials for respiratory tract infections can increase the global burden of antimicrobial resistance.

The course explores the causes of respiratory tract infections and the epidemiological effect of SARS-CoV-2 pandemic on RTIs and antimicrobial prescribing. It also explores antimicrobial resistance and diagnostics before discussing the role of vaccines in reducing antimicrobial resistance.

Learners will receive a certificate of completion upon finishing the course.

Meet the Educators

Dr E. David G. McIntosh AM is a paediatrician, vaccinologist and infectious disease specialist. He is chair of the ISAC Immunisations and Vaccines Working Group.

He is currently supporting MSD Vaccines in the development of vaccines.

Previously, he worked on pneumococcal, meningococcal, dengue and other vaccines in Wyeth, Novartis and Takeda. He also worked on the antibiotics tigecycline and piperacillin-tazobactam, and the anti-parasitic agent moxidectin. He has worked in Papua New Guinea, the Northern Territory of Australia, New Zealand, The UK, The Netherlands, Russia and Latin America.

Prof. Mario Ramirez is an Associate Professor of Microbiology at the Faculdade de Medicina of Universidade de Lisboa and the Head of the Molecular Microbiology and Infection laboratory of the Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal. 

His research interests have focused on the Streptococcus genus and have included the study of bacterial populations, epidemiology of infections, antimicrobial resistance, novel tools in molecular typing analysis as well as more fundamental aspects of the biology of streptococci. He has also been involved in developing new methods and software for the analysis of microbial typing data and genomic information derived from high throughput sequencing technologies.